OxyContin Patent

     MANHATTAN – Though Amneal Pharmaceuticals infringed on Purdue Pharma’s patent with its generic version of the blockbuster drug OxyContin, Purdue’s patent is invalid for obviousness, a federal judge ruled, echoing a January ruling for Teva.

Exit mobile version